Inventor · disambiguated record
Roy Louis Maute
Also filed as: MAUTE ROY LOUIS
11 granted patents·4 pending applications·151 citations·filing 2015–2023
90Inventor score
Top patents by PatentIndex Score
15 records- 0197US9562087B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Feb 7, 2017·45 cites·30 claims
- 0297US9546206B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Jan 17, 2017·33 cites·27 claims
- 0396US9845345B2SIRP polypeptide compositions and methods of useAB INITIO BIOTHERAPEUTICS INC·Filed 2016·Granted Dec 19, 2017·44 cites·23 claims
- 0494US10774125B2SIRP-gamma polypeptide compositions and methods of useAB INITIO BIOTHERAPEUTICS INC·Filed 2017·Granted Sep 15, 2020·10 cites·17 claims
- 0594US10316094B2Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistanceUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Jun 11, 2019·9 cites·17 claims
- 0693US10800830B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Oct 13, 2020·6 cites·17 claims
- 0790US11407801B2SIRP-gamma polypeptide compositions and treatment of cancerAB INITIO BIOTHERAPEUTICS INC·Filed 2020·Granted Aug 9, 2022·2 cites·6 claims
- 0884US2024174729A1High affinity pd-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 0980US10889649B2Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistanceUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Jan 12, 2021·2 cites·58 claims
- 1072US11814419B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Nov 14, 2023·0 cites·25 claims
- 1172US11459388B2Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistanceUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Oct 4, 2022·0 cites·20 claims
- 1267US2024124578A1Combination therapies for treating myelodysplastic syndromes and acute myeloid leukemiaFORTY SEVEN INC·Filed 2023·Application pending·0 cites
- 1360US11795223B2Combination therapies for treating myelodysplastic syndromes and acute myeloid leukemiaFORTY SEVEN INC·Filed 2020·Granted Oct 24, 2023·0 cites·12 claims
- 1450US2021147568A1Anti-cd47 based treatment of blood cancerFORTY SEVEN INC·Filed 2020·Application pending·0 cites
- 1549US2022220214A1Apj modulators and uses thereofAB INITIO BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roy Louis Maute files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →